Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,949.53 +709.16 (+1.18%) CMC Crypto 200
1,266.46 -17.37 (-1.35%)
MEDP Dec 2024 330.000 call
| Previous close | 93.27 |
| Open | N/A |
| Bid | 99.10 |
| Ask | 109.00 |
| Strike | 330.00 |
| Expiry date | 2024-12-20 |
| Day's range | 93.27 - 93.27 |
| Contract range | N/A |
| Volume | |
| Open interest | 8 |
ZacksMedpace Holdings, Inc. (MEDP) Hit a 52 Week High, Can the Run Continue?
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Business WireMedpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024
CINCINNATI, June 26, 2024--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024. The Company will host a conference call the following morning, Tuesday, July 23, 2024, at 9:00 a.m. ET to discuss these results.
Simply Wall St.3 Undervalued Stocks With Intrinsic Discounts Ranging From 26.7% To 47.9%
As global markets exhibit mixed signals with modest gains in some regions and cautious consumer behavior in others, investors are keenly observing market trends for potential opportunities. In such a landscape, identifying undervalued stocks becomes crucial as they may offer intrinsic value that isn't fully recognized by the broader market yet.
